Daily non-political popular news in brief.
Study finds major variation in Medicare Rx drug costs
01-10-2007 · EurekAlert!As Congress debates changes to the Medicare Part D prescription drug plans, a new study finds tremendous variation in what seniors in different states pay for the same medications, even if they choose the lowest-cost Part D plans in their areas. The highest costs often occur in the lowest-income, lowest cost-of-living areas.
Read more »
Keywords: study, major, variation, medicare, drug, costs, cost
« Previous | Next »
Similar news on "Study finds major variation in Medicare Rx drug costs":
- Mass drug treatment for elephantiasis is affordable compared with other public health programs
10-30-2007 · EurekAlert!
Once-yearly administration of two antiparasitic drugs to control lymphatic filariasis (elephantiasis) costs just $0.06 to $2.23 per person treated, making it comparatively inexpensive, according to a major new international study of treatment costs.
Similar news · Read more »
- New study looks at long-term drug costs for treating AIDS in Brazil
11-12-2007 · EurekAlert!
AIDS continues to be a staggering global public health problem. However, little is known about the long-term costs associated with providing drugs to AIDS patients in developing countries. To study those long-term cost trends, researchers from the Harvard School of Public Health have performed the first detailed analysis of AIDS drug cost trends in Brazil.
Similar news · Read more »
- Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
06-11-2007 · EurekAlert!
Slicing certain pills in half could slice a hefty amount off of Americas prescription drug costs. While only some types of pills can be split safely, they include popular cholesterol-lowering drugs. Now, the first prospective randomized controlled trial of pill-splitting gives more evidence of how the practice could be used.
Similar news · Read more »
- Cost control measures limit patient and physician choice in psychotropic medications
03-01-2007 · EurekAlert!
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University.
Similar news · Read more »
- Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
06-26-2007 · EurekAlert!
New research carried out by researchers in Nepal has shown that a new and affordable drug, Gatifloxacin, may be more effective at treating typhoid fever than the drug currently recommended by the World Health Organization. The study, funded by the Wellcome Trust, has implications for the treatment of typhoid particularly in areas where drug resistance is a major problem.
Similar news · Read more »
- Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
06-27-2007 · EurekAlert!
New research carried out by researchers in Nepal has shown that a new and affordable drug, gatifloxacin, may be more effective at treating typhoid fever than the drug currently recommended by the World Health Organization. The study, funded by the Wellcome Trust, has implications for the treatment of typhoid particularly in areas where drug resistance is a major problem. The results are published in the June 27 issue of the online, open-access journal PLoS ONE.
Similar news · Read more »
- Medication costs infrequently addressed when newly prescribed, UCLA study finds
11-08-2006 · EurekAlert!
A new UCLA study has found that physicians discuss cost and aspects of obtaining newly prescribed medications only about one-third of the time during patient/doctor interactions.But questions about pricing and prescription drug insurance coverage are critical -- the high costs of drugs, including out-of-pocket payouts such as co-payments, are linked to patient non-adherence in maintaining their dosage schedules
Similar news · Read more »
- Assessing the cost of juvenile arthritis
01-31-2007 · EurekAlert!
A new study examined direct medical costs of children with JIA and found that the economic impact was substantial.
Similar news · Read more »
- OPICAN study in 7 Canadian cities reveals prescription opioid abuse more prevalent than heroin
11-20-2006 · EurekAlert!
A new study conducted in seven Canadian cities reveals that prescription opioids, and not heroin, are the major form of illicit opioid use. These findings raise questions about the current focus of Canada's drug control policy and treatment programs.
Similar news · Read more »
- Study finds drug spending caps cause some seniors to quit taking key medicines
09-11-2007 · EurekAlert!
Many seniors quit taking drugs for chronic illnesses such as diabetes and high blood pressure when they exceed their drug plan's yearly spending limits, according to a RAND Corp. study. The report, which examines the behavior of seniors enrolled in a private health plan, provides insight into how seniors may act under provisions of Medicare's new drug benefit plan that will leave about one-third of enrollees without drug coverage for some part of each benefit year.
Similar news · Read more »
